+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

The Basal Cell Carcinoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • ID: 5509661
  • Report
  • November 2021
  • Region: Global
  • 156 Pages
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.,
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company plc
Basal cell carcinoma is a type of skin cancer. Basal cell carcinoma begins in the basal cells a type of cell within the skin that produces new skin cells as old ones die off. Basal cell carcinoma often appears as a slightly transparent bump on the skin, though it can take other forms. Basal cell carcinoma occurs most often on areas of the skin that are exposed to the sun, such as head and neck. It is more common among fair-skinned people with sun exposure and is very rare among dark-skinned people.



Market Dynamics

Key players operating in the global basal cell carcinoma market are focusing on adoption of growth strategies such as product launch, regulatory approval, and research and development for the treatment of basal cell carcinoma, which is expected to drive the market growth during the forecast period. For instance, in January 2021, Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, announced dose administration for the first patient in a phase 2a clinical study of the company's lead drug candidate, STP705, for the treatment of cutaneous basal cell carcinoma. Moreover, in November 18 2021, Verrica Pharmaceuticals Inc., a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, announced that the U.S. Food and Drug Administration had accepted the company’s investigational new drug application for LTX-315, a potential first-in-class oncolytic peptide, for the treatment of basal cell carcinoma. The company expects to initiate its phase II trial of LTX-315 in basal cell carcinoma in the first quarter of 2022.

Key features of the study:

  • This report provides in-depth analysis of the global basal cell carcinoma market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global basal cell carcinoma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Novartis AG., Bausch & Lomb Incorporated., Allergan, Perrigo Company plc, Taro Pharmaceutical Industries Ltd., Provectus Biopharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Sanofi, and Mylan N.V.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global basal cell carcinoma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global basal cell carcinoma market

Detailed Segmentation:


Global Basal Cell Carcinoma Market, By Treatment Type :

  • Surgical
  • Surgical Excision
  • Electrodessication & Cutterage ED&C
  • Moh's Surgery
  • Cryosurgery
  • Drugs
  • Topical Treatment
  • Advanced Medication
  • Other
  • Others
  • Radiation Therapy
  • Photodynamic Therapy PDT
  • Laser Therapy
  • Global Basal Cell Carcinoma Market, By End User :
  • Hospitals
  • Specialty Clinics
  • Others
  • Global Basal Cell Carcinoma Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Merck & Co., Inc.,*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Bausch & Lomb Incorporated.
  • Allergan
  • Perrigo Company plc
  • Taro Pharmaceutical Industries Ltd
  • Provectus Biopharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Mylan N.V.
Frequently Asked Questions about the Basal Cell Carcinoma Market

What is the estimated value of the Basal Cell Carcinoma Market?

The Basal Cell Carcinoma Market was estimated to be valued at US$6721.4 Million in 2021.

What is the growth rate of the Basal Cell Carcinoma Market?

The growth rate of the Basal Cell Carcinoma Market is 7.9%, with an estimated value of US$11458.3 Million by 2028.

What is the forecasted size of the Basal Cell Carcinoma Market?

The Basal Cell Carcinoma Market is estimated to be worth US$11458.3 Million by 2028.

Who are the key companies in the Basal Cell Carcinoma Market?

Key companies in the Basal Cell Carcinoma Market include Merck & Co., Inc.,, Sun Pharmaceutical Industries Ltd, Novartis AG, Bausch & Lomb Incorporated., Allergan, Perrigo Company plc, Taro Pharmaceutical Industries Ltd, Provectus Biopharmaceuticals, Inc. and La Roche Ltd.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Allergan
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.,
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company plc

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By End-User
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Pipeline Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Developments
  • Epidemiology
  • PEST Analysis
  • Brand Analysis

4. Global Basal Cell Carcinoma Market– Impact of Coronavirus (COVID-19) Pandemic
  • Economic Impact
  • Impact on Clinical Trials and Drug Development

5. Global Basal Cell Carcinoma Market, By Treatment Type, 2017 – 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 – 2028
  • Segment Trends
  • Surgical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  • Surgical Excision
  • Electrodessication & Cutterage ED&C
  • Moh's Surgery
  • Cryosurgery
  • Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  • Topical Treatment
  • Advanced Medication
  • Other
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  • Radiation Therapy
  • Photodynamic Therapy PDT
  • Laser Therapy

6. Global Basal Cell Carcinoma Market, By End User, 2017 – 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 – 2028
  • Segment Trends
  • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
  • Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)

7. Global Basal Cell Carcinoma Market, By Region, 2017 – 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017–2028
  • Regional Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2017 – 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape
  • Heat Map Analysis
  • Market Share Analysis
  • Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Novartis AG.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Bausch & Lomb Incorporated.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Allergan
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Perrigo Company plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Taro Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Provectus Biopharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

9. Section
  • Research Methodology
  • About Us
Note: Product cover images may vary from those shown
  • Merck & Co., Inc.,
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Bausch & Lomb Incorporated.
  • Allergan
  • Perrigo Company plc
  • Taro Pharmaceutical Industries Ltd
  • Provectus Biopharmaceuticals, Inc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Mylan N.V.
Note: Product cover images may vary from those shown